437 related articles for article (PubMed ID: 14521485)
21. New treatments for the motor symptoms of Parkinson's disease.
Vijverman AC; Fox SH
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):761-77. PubMed ID: 25318835
[TBL] [Abstract][Full Text] [Related]
22. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
[TBL] [Abstract][Full Text] [Related]
23. Levodopa-related wearing-off in Parkinson's disease: identification and management.
Pahwa R; Lyons KE
Curr Med Res Opin; 2009 Apr; 25(4):841-9. PubMed ID: 19228103
[TBL] [Abstract][Full Text] [Related]
24. Treatment of levodopa-induced motor complications.
Stocchi F; Tagliati M; Olanow CW
Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
[TBL] [Abstract][Full Text] [Related]
25. The evolution of pharmacological treatment for Parkinson's disease.
Almeida QJ; Hyson HC
Recent Pat CNS Drug Discov; 2008 Jan; 3(1):50-4. PubMed ID: 18221241
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.
Deleu D; Northway MG; Hanssens Y
Clin Pharmacokinet; 2002; 41(4):261-309. PubMed ID: 11978145
[TBL] [Abstract][Full Text] [Related]
27. Monoamine Oxidase B Inhibitors in Parkinson's Disease.
Dezsi L; Vecsei L
CNS Neurol Disord Drug Targets; 2017; 16(4):425-439. PubMed ID: 28124620
[TBL] [Abstract][Full Text] [Related]
28. 'Bad guys' among the antiparkinsonian drugs.
Pirtosek Z
Psychiatr Danub; 2009 Mar; 21(1):114-8. PubMed ID: 19270634
[TBL] [Abstract][Full Text] [Related]
29. Parkinson's disease therapy: treatment of early and late disease.
Jankovic J
Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303
[TBL] [Abstract][Full Text] [Related]
30. [The new Parkinson's disease drugs].
Hasegawa K
Nihon Rinsho; 2000 Oct; 58(10):2066-71. PubMed ID: 11068448
[TBL] [Abstract][Full Text] [Related]
31. Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease.
Caslake R; Macleod A; Ives N; Stowe R; Counsell C
Cochrane Database Syst Rev; 2009 Oct; (4):CD006661. PubMed ID: 19821381
[TBL] [Abstract][Full Text] [Related]
32. New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategy.
Hauser RA
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S17-21. PubMed ID: 20082983
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of motor symptoms in Parkinson's disease].
Morís-De la Tassa G; Arias-Rodríguez M
Rev Neurol; 2009 Jan; 48 Suppl 1():S27-31. PubMed ID: 19222012
[TBL] [Abstract][Full Text] [Related]
34. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
Bhatia K; Brooks DJ; Burn DJ; Clarke CE; Playfer J; Sawle GV; Schapira AH; Stewart D; Williams AC
Hosp Med; 1998 Jun; 59(6):469-80. PubMed ID: 9775275
[TBL] [Abstract][Full Text] [Related]
35. Other pharmacological treatments for motor complications and dyskinesias.
Waters C
Mov Disord; 2005; 20 Suppl 11():S38-44. PubMed ID: 15822104
[TBL] [Abstract][Full Text] [Related]
36. GOCOVRI
Müller T
Neurodegener Dis Manag; 2022 Feb; 12(1):15-28. PubMed ID: 34918543
[TBL] [Abstract][Full Text] [Related]
37. Medical treatment of essential tremor and Parkinson's disease.
Uitti RJ
Geriatrics; 1998 May; 53(5):46-8, 53-7. PubMed ID: 9597979
[TBL] [Abstract][Full Text] [Related]
38. Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson's Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLE.
Cattaneo C; Sardina M; Bonizzoni E
J Parkinsons Dis; 2016; 6(1):165-73. PubMed ID: 26889632
[TBL] [Abstract][Full Text] [Related]
39. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
; Gray R; Ives N; Rick C; Patel S; Gray A; Jenkinson C; McIntosh E; Wheatley K; Williams A; Clarke CE
Lancet; 2014 Sep; 384(9949):1196-205. PubMed ID: 24928805
[TBL] [Abstract][Full Text] [Related]
40. Drug treatment of Parkinson's disease.
Quinn N
BMJ; 1995 Mar; 310(6979):575-9. PubMed ID: 7888935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
